These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33881161)

  • 41. COPD patients prescribed inhaled corticosteroid in general practice: Based on disease characteristics according to guidelines?
    Savran O; Godtfredsen N; Sørensen T; Jensen C; Ulrik CS
    Chron Respir Dis; 2019; 16():1479973119867949. PubMed ID: 31431060
    [TBL] [Abstract][Full Text] [Related]  

  • 42. First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis.
    Price D; Miravitlles M; Pavord I; Thomas M; Wedzicha J; Haughney J; Bichel K; West D
    NPJ Prim Care Respir Med; 2016 Nov; 26():16061. PubMed ID: 27808096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The GOLD initiative 2011: a change of paradigm?
    Rodríguez-Roisin R; Agustí A
    Arch Bronconeumol; 2012 Aug; 48(8):286-9. PubMed ID: 22537593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The GOLD classification has advanced understanding of COPD.
    Calverley PM
    Am J Respir Crit Care Med; 2004 Aug; 170(3):211-2; discussion 214. PubMed ID: 15280171
    [No Abstract]   [Full Text] [Related]  

  • 45. Caring for patients with COPD and COVID-19: a viewpoint to spark discussion.
    Simons SO; Hurst JR; Miravitlles M; Franssen FME; Janssen DJA; Papi A; Duiverman ML; Kerstjens HAM
    Thorax; 2020 Dec; 75(12):1035-1039. PubMed ID: 32878969
    [No Abstract]   [Full Text] [Related]  

  • 46. A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications.
    Ding B; Small M; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1527-1537. PubMed ID: 28579771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. COPD dashboard: about official documents, authors, science, health status and BOARDs.
    Schünemann HJ
    Eur Respir J; 2008 Feb; 31(2):238-40. PubMed ID: 18238946
    [No Abstract]   [Full Text] [Related]  

  • 48. Pulmonologists Adherence to the Chronic Obstructive Pulmonary Disease GOLD Guidelines: A Goal to Improve.
    Rajnoveanu RM; Rajnoveanu AG; Ardelean AB; Todea DA; Pop CM; Antoniu SA; Motoc NS; Chis AF; Fildan AP; Man MA
    Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32825456
    [No Abstract]   [Full Text] [Related]  

  • 49. [Recurring obstructive bronchitis and asthmatic bronchitis in preschool aged children].
    Götz M; Eber E; Frischer T; Horak E; Kurz H; Riedler J; Schmitzberger R; Zach M
    Wien Klin Wochenschr; 2006 May; 118(9-10):302-6. PubMed ID: 16810490
    [No Abstract]   [Full Text] [Related]  

  • 50. From Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines to current clinical practice : an overview of the pharmacological therapy of stable chronic obstructive pulmonary disorder.
    Incalzi RA; Corsonello A; Pedone C; Masotti G; Bellia V; Grassi V; Rengo F
    Drugs Aging; 2006; 23(5):411-20. PubMed ID: 16823994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
    Miyazaki M; Nakamura H; Takahashi S; Chubachi S; Sasaki M; Haraguchi M; Terai H; Ishii M; Fukunaga K; Tasaka S; Soejima K; Asano K; Betsuyaku T;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1053-9. PubMed ID: 26082629
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NICE guideline on long covid.
    Sivan M; Taylor S
    BMJ; 2020 Dec; 371():m4938. PubMed ID: 33361141
    [No Abstract]   [Full Text] [Related]  

  • 53. Consequences of Changing the GOLD Reports (2007-2011-2017) on the Treatment Regimen of Patients with COPD.
    Brożek GM; Nowak M; Zejda JE; Jankowski M; Lawson J; Pierzchała W
    COPD; 2019 Apr; 16(2):126-132. PubMed ID: 31161814
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and validation of a claims-based prediction model for COPD severity.
    Macaulay D; Sun SX; Sorg RA; Yan SY; De G; Wu EQ; Simonelli PF
    Respir Med; 2013 Oct; 107(10):1568-77. PubMed ID: 23806285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of stable chronic obstructive pulmonary disease: the GOLD guidelines.
    Lee H; Kim J; Tagmazyan K
    Am Fam Physician; 2013 Nov; 88(10):655-63, 663B-F. PubMed ID: 24364481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Stage and prognosis of COPD].
    Akashiba T
    Nihon Rinsho; 2003 Dec; 61(12):2089-93. PubMed ID: 14674315
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort.
    Jochmann A; Scherr A; Jochmann DC; Miedinger D; Török SS; Chhajed PN; Tamm M; Leuppi JD
    Swiss Med Wkly; 2012; 142():w13567. PubMed ID: 22481636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The burden of COPD in Africa: a literature review and prospective survey of the availability of spirometry for COPD diagnosis in Africa.
    Mehrotra A; Akanbi MO; Gordon SB
    Trop Med Int Health; 2009 Aug; 14(8):840-8. PubMed ID: 19702594
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Severe chronic obstructive pulmonary disease.
    Yoneda KY; Harper RW; Louie S
    Clin Rev Allergy Immunol; 2003 Oct; 25(2):151-63. PubMed ID: 14573882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [New therapeutic approaches to COPD].
    Pfeifer M
    Internist (Berl); 2004 Dec; 45(12):1395-401. PubMed ID: 15517127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.